• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical decision rules for infectious risk stratification of children with febrile neutropenia: Are we looking for the Yeti?

作者信息

Castagnola Elio, Dufour Carlo

机构信息

Pole of Hematology and Oncology, Department of Pediatrics, IRCCS Istituto Giannina Gaslini, Via G.Gaslini, 5, 16147 Genoa, Italy.

出版信息

EClinicalMedicine. 2020 Jan 25;19:100262. doi: 10.1016/j.eclinm.2020.100262. eCollection 2020 Feb.

DOI:10.1016/j.eclinm.2020.100262
PMID:32021968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6994297/
Abstract
摘要

相似文献

1
Clinical decision rules for infectious risk stratification of children with febrile neutropenia: Are we looking for the Yeti?发热性中性粒细胞减少症患儿感染风险分层的临床决策规则：我们是在寻找雪人吗？
EClinicalMedicine. 2020 Jan 25;19:100262. doi: 10.1016/j.eclinm.2020.100262. eCollection 2020 Feb.
2
Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia.预测化疗引起的发热性中性粒细胞减少症患儿严重感染的风险。
Curr Opin Hematol. 2012 Jan;19(1):39-43. doi: 10.1097/MOH.0b013e32834da951.
3
Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis.哪些决策规则符合发热性中性粒细胞减少症儿童的方法学标准？系统评价和分析的结果。
Pediatr Blood Cancer. 2014 Oct;61(10):1786-91. doi: 10.1002/pbc.25106. Epub 2014 Jun 29.
4
The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.C反应蛋白、白细胞介素-8和单核细胞趋化蛋白在血液系统恶性肿瘤发热性中性粒细胞减少儿童风险分层中的诊断价值。
J Pediatr Hematol Oncol. 2007 Mar;29(3):131-6. doi: 10.1097/MPH.0b013e3180308770.
5
Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.儿童血液肿瘤患者发热性中性粒细胞减少症的风险分层管理：一项法国全国性调查的结果
Pediatr Blood Cancer. 2016 Dec;63(12):2167-2172. doi: 10.1002/pbc.26121. Epub 2016 Aug 28.
6
Advances in management of low-risk febrile neutropenia.低危发热性中性粒细胞减少症的管理进展。
Curr Opin Pediatr. 2012 Feb;24(1):40-5. doi: 10.1097/MOP.0b013e32834c4b12.
7
Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India.印度一家儿科肿瘤病房中发热性中性粒细胞减少症患儿风险分层的验证
Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26333. Epub 2016 Nov 15.
8
Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.预测化疗引起的发热性中性粒细胞减少症儿童发生严重细菌感染的风险。
Pediatr Blood Cancer. 2010 Oct;55(4):662-7. doi: 10.1002/pbc.22586.
9
Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.用于预防急性淋巴细胞白血病患儿骨髓抑制治疗所致发热性中性粒细胞减少症的集落刺激因子
Cochrane Database Syst Rev. 2005 Jul 20(3):CD004139. doi: 10.1002/14651858.CD004139.pub2.
10
Outcomes and infectious etiologies of febrile neutropenia in non-immunocompromised children who present in an emergency department.急诊科就诊的非免疫功能低下儿童发热性中性粒细胞减少症的结局及感染病因
Eur J Clin Microbiol Infect Dis. 2016 Oct;35(10):1667-72. doi: 10.1007/s10096-016-2708-7. Epub 2016 Jun 18.

本文引用的文献

1
Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules.癌症合并发热性中性粒细胞减少症患儿的风险分层：九种临床决策规则的全国性、前瞻性、多中心验证
EClinicalMedicine. 2020 Jan 7;18:100220. doi: 10.1016/j.eclinm.2019.11.013. eCollection 2020 Jan.
2
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.六种儿科发热伴中性粒细胞减少症临床决策规则的外部验证。
Pediatr Infect Dis J. 2018 Apr;37(4):329-335. doi: 10.1097/INF.0000000000001777.
3
Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.预测癌症患儿的感染并发症：一项外部验证研究。
Br J Cancer. 2017 Jul 11;117(2):171-178. doi: 10.1038/bjc.2017.154. Epub 2017 Jun 13.
4
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.儿童癌症和造血干细胞移植受者发热与中性粒细胞减少管理指南：2017 年更新版。
J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1.
5
Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.预测儿童发热性中性粒细胞减少症发作中微生物学定义的感染：全球个体参与者数据多变量荟萃分析
Br J Cancer. 2016 Mar 15;114(6):623-30. doi: 10.1038/bjc.2016.28. Epub 2016 Mar 8.
6
Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia.癌症患儿和高危发热性中性粒细胞减少症患儿严重脓毒症风险预测模型的前瞻性验证
Pediatr Infect Dis J. 2013 Dec;32(12):1318-23. doi: 10.1097/01.inf.0000436128.49972.16.
7
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.诊断试验和策略的证据质量分级及推荐强度
BMJ. 2008 May 17;336(7653):1106-10. doi: 10.1136/bmj.39500.677199.AE.
8
Simplifying likelihood ratios.简化似然比
J Gen Intern Med. 2002 Aug;17(8):646-9. doi: 10.1046/j.1525-1497.2002.10750.x.